Controlled-release morphine (MST contin) in advanced cancer. The European experience
- 1 June 1989
- Vol. 63 (11) , 2378-2382
- https://doi.org/10.1002/1097-0142(19890601)63:11<2378::aid-cncr2820631150>3.0.co;2-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- EXPLANATION FOR POTENCY OF REPEATED ORAL DOSES OF MORPHINE?The Lancet, 1987
- Controlled release morphine tablets: a double‐blind trial in patients with advanced cancerAnaesthesia, 1987
- Management of Cancer Pain With Oral Controlled‐Release Morphine SulfateThe Journal of Clinical Pharmacology, 1987
- Review article : Opioid analgesics in the management of pain in patients with cancer. A reviewPalliative Medicine, 1987
- Dosage Range Study of Morphine Sulfate Controlled-ReleaseAmerican Journal of Clinical Oncology, 1986
- Steady-State Pharmacokinetics of Controlled Release Oral Morphine Sulphate in Healthy SubjectsClinical Pharmacokinetics, 1986
- MORPHINE-6-GLUCURONIDE, AN IMPORTANT FACTOR IN INTERPRETING MORPHINE RADIOIMMUNOASSAYSThe Lancet, 1985
- MORPHINE METABOLISM: DOES THE RENAL HYPOTHESIS HOLD WATER?The Lancet, 1985
- Slow-release morphineBMJ, 1981
- CONTROLLED RELEASE MORPHINE TABLETSThe Lancet, 1981